AbbVie Inc.ABBVNYSE
Loading
Asset Growth Recovery in ProgressRecovering
Percentile Rank49
5Y CAGR-40.7%
Year-over-Year Change
Year-over-year total asset growth rate
5Y CAGR
-40.7%/yr
Long-term compound
Percentile
P49
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 0.05% |
| Q3 2025 | -2.39% |
| Q2 2025 | 0.75% |
| Q1 2025 | 0.74% |
| Q4 2024 | -5.76% |
| Q3 2024 | 1.05% |
| Q2 2024 | -4.66% |
| Q1 2024 | 10.51% |
| Q4 2023 | -1.11% |
| Q3 2023 | 0.63% |
| Q2 2023 | 0.61% |
| Q1 2023 | -3.07% |
| Q4 2022 | -1.78% |
| Q3 2022 | -1.30% |
| Q2 2022 | -0.02% |
| Q1 2022 | -2.26% |
| Q4 2021 | -1.56% |
| Q3 2021 | 0.60% |
| Q2 2021 | -1.68% |
| Q1 2021 | -0.04% |
| Q4 2020 | 0.63% |
| Q3 2020 | 0.06% |
| Q2 2020 | 63.96% |
| Q1 2020 | 2.34% |
| Q4 2019 | 49.92% |
| Q3 2019 | 4.02% |
| Q2 2019 | 0.66% |
| Q1 2019 | -4.35% |
| Q4 2018 | -10.30% |
| Q3 2018 | 7.34% |
| Q2 2018 | -11.11% |
| Q1 2018 | -2.04% |
| Q4 2017 | 2.83% |
| Q3 2017 | 2.76% |
| Q2 2017 | 2.03% |
| Q1 2017 | -0.66% |
| Q4 2016 | -0.79% |
| Q3 2016 | -0.87% |
| Q2 2016 | 25.11% |
| Q1 2016 | 1.26% |